SS-31 (also known as Elamipretide) is a mitochondria-targeting tetrapeptide designed to selectively bind to cardiolipin, a key phospholipid in the inner mitochondrial membrane.
By stabilizing mitochondrial structure and function, SS-31 has been widely studied for its role in improving cellular energy production and reducing oxidative stress.
Originally developed for mitochondrial dysfunction and age-related diseases, SS-31 has demonstrated significant potential in enhancing ATP production, protecting against reactive oxygen species (ROS), and improving overall cellular resilience in experimental models.
Researched Benefits:
- Facilitates investigation of mitochondrial bioenergetics and ATP synthesis
- Supports analysis of oxidative stress reduction and ROS modulation
- Enables studies on cardiolipin stabilization and membrane integrity
- Useful for exploring age-related cellular decline and fatigue models
- Assists in modeling mitochondrial dysfunction in metabolic and degenerative conditions
Description
SS-31 (50mg) is a research-grade mitochondrial peptide utilized in advanced cellular and metabolic studies. Produced using high-purity synthesis and strict quality control, it ensures consistency and reliability for laboratory applications.
Key Features:
- Mitochondria-targeted peptide with cardiolipin affinity
- High-purity synthesis with rigorous batch testing
- Consistent performance in experimental settings
- Lyophilized for long-term stability and storage
Applications:
- Investigates mitochondrial function and energy metabolism
- Explores oxidative stress and cellular aging pathways
- Supports research on muscle endurance and recovery models
- Examines therapeutic potential in degenerative and metabolic disorders
SS-31 is recognized in research for its ability to restore mitochondrial efficiency and protect against oxidative damage, making it a valuable tool for studying cellular energy systems and age-related decline.
